A detailed history of Alps Advisors Inc transactions in Ideaya Biosciences, Inc. stock. As of the latest transaction made, Alps Advisors Inc holds 64,890 shares of IDYA stock, worth $1.74 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
64,890
Previous 59,052 9.89%
Holding current value
$1.74 Million
Previous $2.07 Million 0.87%
% of portfolio
0.01%
Previous 0.01%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$30.37 - $43.05 $177,300 - $251,325
5,838 Added 9.89%
64,890 $2.06 Million
Q2 2024

Aug 13, 2024

BUY
$34.37 - $43.46 $243,030 - $307,305
7,071 Added 13.6%
59,052 $2.07 Million
Q1 2024

May 14, 2024

BUY
$34.2 - $47.13 $325,960 - $449,196
9,531 Added 22.45%
51,981 $2.28 Million
Q4 2023

Feb 14, 2024

SELL
$24.59 - $35.83 $713 - $1,039
-29 Reduced 0.07%
42,450 $1.51 Million
Q3 2023

Nov 14, 2023

BUY
$21.07 - $29.77 $7,753 - $10,955
368 Added 0.87%
42,479 $1.15 Million
Q2 2023

Aug 14, 2023

BUY
$13.33 - $25.53 $561,339 - $1.08 Million
42,111 New
42,111 $989,000
Q3 2022

Nov 14, 2022

SELL
$9.24 - $15.79 $14,007 - $23,937
-1,516 Reduced 6.61%
21,409 $319,000
Q2 2022

Aug 11, 2022

BUY
$8.28 - $13.88 $189,818 - $318,199
22,925 New
22,925 $316,000

Others Institutions Holding IDYA

About IDEAYA Biosciences, Inc.


  • Ticker IDYA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 48,067,700
  • Market Cap $1.29B
  • Description
  • IDEAYA Biosciences, Inc., a synthetic lethality-focused precision medicine oncology company, focuses on the discovery and development of targeted therapeutics for patient populations selected using molecular diagnostics. The company's lead product candidates include IDE397, a methionine adenosyltransferase 2a inhibitor that is in Phase I clinica...
More about IDYA
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.